Sfoglia per ???browse.type.metadata.subjectIsicrui???
Pharmacogenomic Response of Inhaled Corticosteroids for the Treatment of Asthma: Considerations for Therapy
2020-01-01 Cazzola, M; Rogliani, P; Calzetta, L; Matera, Mg
Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary disease
2018-01-01 Matera, Mg; Rinaldi, B; Page, C; Rogliani, P; Cazzola, M
Pharmacokinetic/pharmacodynamic approaches to drug delivery design for inhalation drugs
2021-01-01 Matera, Mg; Calzetta, L; Ora, J; Rogliani, P; Cazzola, M
Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma
2018-01-01 Matera, Mg; Rogliani, P; Calzetta, L; Cazzola, M
Pharmacokinetics and pharmacodynamics of inhaled corticosteroids for asthma treatment
2019-01-01 Matera, Mg; Rinaldi, B; Calzetta, L; Rogliani, P; Cazzola, M
Pharmacological assessment of the onset of action of aclidinium and glycopyrronium versus tiotropium in COPD patients and human isolated bronchi
2015-01-01 Rogliani, P; Calzetta, L; Ora, J; Lipsi, R; Segreti, A; Matera, M; Cazzola, M
Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells
2016-01-01 Cazzola, M; Calzetta, L; Puxeddu, E; Ora, J; Facciolo, F; Rogliani, P; Matera, M
Pharmacological characterization of adenosine receptors on isolated human bronchi
2011-12-01 Calzetta, L; Spina, D; Cazzola, M; Page, C; Facciolo, F; Rendina, E; Matera, M
Pharmacological characterization of the interaction between tiotropium and olodaterol administered at 5:5 concentration-ratio in equine bronchi
2017-01-01 Calzetta, L; Rogliani, P; Mattei, M; Alfonsi, P; Cito, G; Pistocchini, E; Cazzola, M; Matera, Mg
Pharmacological characterization of the interaction between tiotropium bromide and olodaterol on human bronchi and small airways
2019-01-01 Calzetta, L; Rogliani, P; Page, C; Rinaldi, B; Cazzola, M; Matera, Mg
Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi
2017-01-01 Calzetta, L; Rogliani, P; Facciolo, F; Rendina, E; Cazzola, M; Matera, M
Pharmacological Interpretation of the Efficacy of Ensifentrine in Chronic Obstructive Pulmonary Disease: Insights from ENHANCE Trials
2024-01-15 Calzetta, L; Cazzola, M; Rogliani, P
Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation
2017-01-01 Cazzola, M; Calzetta, L; Facciolo, F; Rogliani, P; Matera, M
Pharmacological management of adult patients with acute respiratory distress syndrome
2020-01-01 Matera, Mg; Rogliani, P; Bianco, A; Cazzola, M
Pharmacological management of COVID-19 patients with ARDS (CARDS): A narrative review
2020-01-01 Matera, Mg; Rogliani, P; Calzetta, L; Cazzola, M
Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure
2010-01-01 Matera, M; Martuscelli, E; Cazzola, M
Pharmacological treatment and current controversies in COPD
2019-01-01 Cazzola, M; Rogliani, P; Stolz, D; Matera, Mg
Pharmacology and therapeutics of bronchodilators
2012-06-01 Cazzola, M; Page, C; Calzetta, L; Matera, M
Pharmacology and Therapeutics of Bronchodilators Revisited
2020-01-01 Matera, Mg; Page, Cp; Calzetta, L; Rogliani, P; Cazzola, M
Pharmacology of the small airways [Farmacologia delle piccole vie aeree]
2009-01-01 Cazzola, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile